Non Surgical Ways To Evaluate Suspected Endometriosis

Endometriosis is a chronic inflammatory condition in which tissue resembling the uterine lining grows outside the uterus, commonly affecting the ovaries, pelvic peritoneum, bowel, or bladder. Suspected endometriosis can often be evaluated without immediate surgery through a structured symptom history, pelvic examination, transvaginal ultrasound, and—when appropriate—magnetic resonance imaging (MRI). The European Society of Human Reproduction and Embryology (ESHRE) now supports imaging-based evaluation and recognizes that diagnostic laparoscopy is not automatically required before treatment. This approach matters because the World Health Organization estimates that endometriosis affects approximately 10% of reproductive-age women, or about 190 million people worldwide, while diagnosis may still be delayed for years.

Non-Surgical Evaluation of Suspected Endometriosis

Non-surgical evaluation of suspected endometriosis is the process of estimating the likelihood, location, and severity of endometriosis without initially inserting a camera into the abdomen. The evaluation combines clinical history, physical examination, ultrasound, MRI, and assessment of alternative diagnoses. No single non-surgical test reliably identifies every type of endometriosis, particularly small superficial lesions, so clinicians interpret findings as a group rather than treating one negative test as definitive.

ESHRE’s 2022 guideline defines imaging—usually ultrasound or MRI—as an important part of the diagnostic work-up and states that a negative imaging result does not exclude endometriosis, especially superficial peritoneal disease. The guideline also indicates that laparoscopy may be considered when imaging is negative or inconclusive and empirical treatment has been unsuccessful, is unsuitable, or is not desired.

Symptom history as the initial clinical assessment

A symptom history is a structured review of pain, bleeding, fertility, bowel, urinary, sexual, and family-history clues that may raise or lower suspicion. Features that commonly prompt evaluation include severe period pain, pelvic pain between periods, pain during or after sexual intercourse, painful bowel movements, painful urination during menstruation, heavy or irregular bleeding, infertility, fatigue, and symptoms that recur cyclically.

The history should document the age at symptom onset, progression, effect on work or school, response to nonsteroidal anti-inflammatory drugs or hormonal contraception, prior pelvic surgery, and whether a first-degree relative has endometriosis. Symptoms can overlap with adenomyosis, fibroids, irritable bowel syndrome, interstitial cystitis, pelvic-floor dysfunction, and inflammatory bowel disease. Therefore, symptoms are useful for triage and clinical suspicion but cannot independently confirm the disease.

The American College of Obstetricians and Gynecologists has emphasized that pelvic pain and dysmenorrhea should be evaluated in the context of the patient’s history and examination rather than dismissed as normal menstrual discomfort. A symptom diary recording cycle dates, pain location, bowel and bladder changes, bleeding, medications, and functional limitations can make the pattern more clinically useful.

Pelvic examination and clinical findings

A pelvic examination is a non-surgical physical assessment of the vulva, vagina, cervix, uterus, adnexa, and pelvic-floor muscles. Findings that can increase suspicion include reduced uterine mobility, a fixed or retroverted uterus, tenderness behind the cervix, tenderness of the uterosacral ligaments, an adnexal mass, or pelvic-floor muscle tenderness.

Examination findings may help identify deep endometriosis, an ovarian endometrioma, pelvic-floor pain, infection, or another pelvic disorder, but a normal examination does not rule out endometriosis. The examination is also valuable for identifying urgent conditions, such as a large adnexal mass, pregnancy-related complications, pelvic infection, or acute ovarian torsion.

Because pain can cause involuntary tightening of the pelvic-floor muscles, the examination should be explained beforehand and adapted to the patient’s comfort and consent. In adolescents, people with prior trauma, and patients who cannot tolerate an internal examination, clinicians may begin with an abdominal examination and external assessment before considering transabdominal imaging.

Imaging for Non-Surgical Endometriosis Evaluation

Imaging evaluates suspected endometriosis by looking for ovarian endometriomas, deep lesions, adhesions, altered pelvic anatomy, and other causes of pelvic symptoms. The main imaging methods are transvaginal ultrasound and pelvic MRI. Their value depends on operator expertise, lesion location, disease size, bowel preparation protocols, equipment, and whether the imaging is performed using an endometriosis-focused protocol.

Transvaginal ultrasound as the usual first-line scan

Transvaginal ultrasound uses a high-frequency probe placed in the vagina to visualize the uterus, ovaries, bladder, rectum, and surrounding pelvic structures. NICE recommends offering a transvaginal ultrasound to people with suspected endometriosis, even when the pelvic examination is normal. It is relatively accessible, does not use ionizing radiation, and can evaluate common alternative diagnoses such as fibroids, ovarian cysts, adenomyosis, and some pelvic masses.

An endometrioma often appears as an ovarian cyst containing homogeneous, low-level internal echoes, sometimes described as a “ground-glass” appearance. Specialized ultrasound can also assess indirect signs of adhesions, including reduced ovarian mobility, reduced movement between pelvic organs, and a negative sliding sign. It may identify deep endometriosis involving the bowel, bladder, vagina, or uterosacral ligaments when performed by an experienced examiner.

Diagnostic performance varies by lesion type. In a Cochrane review, transvaginal ultrasound showed high average sensitivity and specificity for ovarian endometriomas, approximately 93% and 96%, respectively, although individual studies and clinical settings differed. Performance is generally less reliable for small superficial peritoneal lesions, which may not alter the appearance of pelvic organs.

Specialist ultrasound for deep endometriosis

Specialist ultrasound is a systematic examination designed to map deep endometriosis rather than simply check for an ovarian cyst. It can include assessment of the uterus and ovaries, the sliding sign, the anterior and posterior pelvic compartments, the bowel, the bladder, and areas around the uterosacral ligaments.

This technique is most useful when symptoms suggest disease near the bowel or bladder, when surgery may be contemplated, or when the patient needs information about disease location. A positive specialist scan can help guide referral and surgical planning. A negative scan is reassuring for some forms of deep disease but cannot exclude superficial endometriosis or every small lesion.

Patients should ask whether the scan was performed by a clinician experienced in endometriosis imaging and whether the report comments on the sliding sign, ovarian mobility, endometriomas, bowel involvement, bladder involvement, and the posterior compartment. These details are more informative than a report that simply states “normal pelvic ultrasound.”

Pelvic MRI for mapping and complex cases

Pelvic MRI uses magnetic fields and radio waves to produce detailed images of pelvic soft tissues. It is particularly helpful for mapping suspected deep endometriosis, evaluating the bowel or bladder, assessing adenomyosis, characterizing an indeterminate adnexal mass, and planning complex surgery. MRI is also useful when transvaginal ultrasound is not acceptable, technically limited, or inconclusive.

MRI is not automatically more useful than expert ultrasound for every patient. Both modalities can perform well for deep endometriosis and endometriomas, but results depend on protocol and expertise. MRI can also miss superficial peritoneal lesions, so a normal scan does not eliminate the possibility of endometriosis.

NICE recommends considering specialist transvaginal ultrasound or pelvic MRI to diagnose and assess the extent of deep endometriosis, with interpretation by a healthcare professional who has appropriate expertise in gynecological imaging. The report should describe the location and extent of suspected lesions, not merely provide a general impression.

Laboratory Tests and Biomarkers in Suspected Endometriosis

Laboratory testing can support the evaluation of pelvic pain and exclude competing diagnoses, but no routine blood test currently confirms or reliably excludes endometriosis. Tests may be selected according to symptoms and may include a pregnancy test, complete blood count, urinalysis, infection testing, or tests related to gastrointestinal or inflammatory conditions.

CA-125 and other blood markers

CA-125 is a blood marker that can rise in endometriosis, menstruation, pregnancy, pelvic inflammation, fibroids, and some cancers. Its lack of specificity and inconsistent performance mean that it is not recommended as a stand-alone diagnostic test for endometriosis. A normal CA-125 does not rule out disease, and an elevated result does not prove that endometriosis is present.

Research continues into inflammatory proteins, microRNAs, menstrual-blood markers, urine tests, and other biomarkers. However, the ESHRE guideline and NICE guidance do not recommend currently available blood, urine, menstrual-fluid, or tissue biomarkers as replacements for clinical assessment and imaging.

Tests that evaluate alternative explanations

Additional tests should be directed by the symptom pattern. A pregnancy test is important for reproductive-age patients with pelvic pain or abnormal bleeding. Urinalysis may help evaluate urinary infection or blood in the urine. Vaginal or cervical testing may be appropriate when infection is possible. Gastrointestinal assessment may be needed for persistent rectal bleeding, weight loss, anemia, nocturnal symptoms, or a family history of bowel disease.

The purpose of these tests is not to prove endometriosis but to avoid anchoring on one diagnosis. Severe or rapidly worsening pain, fainting, fever, heavy bleeding, a positive pregnancy test, or sudden unilateral pain requires prompt medical assessment because urgent conditions can mimic endometriosis.

Empirical Treatment as a Non-Surgical Diagnostic Strategy

Empirical treatment is a monitored trial of therapy based on a clinical suspicion of endometriosis, without waiting for surgical confirmation. Depending on pregnancy goals and medical history, treatment may include nonsteroidal anti-inflammatory drugs, combined hormonal contraception, progestogens, or other specialist-directed hormonal suppression.

What treatment response can and cannot show

Improvement with hormonal treatment supports the possibility that symptoms are hormonally responsive, but it does not confirm endometriosis because dysmenorrhea, adenomyosis, and some other causes of pelvic pain may also improve. Lack of improvement does not exclude endometriosis because the medication, dose, duration, adherence, side effects, pain mechanism, or coexisting condition may be contributing.

A treatment trial should have a defined goal and review date. Clinicians commonly reassess pain intensity, days of missed activity, bleeding, bowel and bladder symptoms, sexual pain, adverse effects, and pregnancy plans. Treatment decisions should be shared decisions, especially when hormonal suppression affects contraception, fertility timing, mood, bleeding patterns, bone health, or other medical conditions.

When empirical treatment should lead to referral

Referral to gynecology or an endometriosis-focused service is appropriate when symptoms are severe, persistent, recurrent, associated with infertility, accompanied by an endometrioma or suspected deep disease, or inadequately controlled by first-line treatment. Referral is also appropriate when symptoms substantially affect work, education, relationships, sleep, or mental health.

NICE recommends referral when initial treatment is ineffective, not tolerated, or contraindicated, and when endometriosis is suspected or identified with an endometrioma or deep disease. A specialist can coordinate imaging, fertility counseling, pain management, pelvic-floor therapy, and discussion of diagnostic laparoscopy when appropriate.

Limits of Non-Surgical Evaluation

Non-surgical evaluation is highly useful but not perfect. Imaging is better at detecting ovarian endometriomas and deep disease than small superficial implants. Symptoms do not always correlate with lesion size or location: extensive disease may cause few symptoms, while limited disease or pelvic-floor sensitization may cause severe pain.

A negative scan does not always end the evaluation

A normal ultrasound or MRI lowers the likelihood of some forms of endometriosis, particularly large endometriomas or readily visible deep lesions, but it does not exclude superficial peritoneal disease. Persistent symptoms should therefore be reviewed in context rather than dismissed solely because imaging is normal.

The next step may be observation, treatment for suspected endometriosis, evaluation for another diagnosis, referral to a specialist, or laparoscopy. The decision should consider symptom severity, fertility goals, imaging findings, previous treatment, risks of surgery, and the patient’s preference.

Distinguishing endometriosis from overlapping conditions

Endometriosis may coexist with other conditions. Adenomyosis can cause painful and heavy periods; fibroids can cause bleeding and pressure; irritable bowel syndrome can cause abdominal pain and altered bowel habits; interstitial cystitis can cause bladder pain and urinary frequency; and pelvic-floor dysfunction can amplify pain during intercourse or examination.

A multidisciplinary approach may include gynecology, radiology, gastroenterology, urology, physiotherapy, pain medicine, and mental-health support. Addressing overlapping pain mechanisms does not imply that symptoms are psychological or that endometriosis is absent. It recognizes that chronic pelvic pain can involve inflammatory, muscular, visceral, and nervous-system processes at the same time.

Practical Non-Surgical Evaluation Pathway

A practical pathway begins with a detailed history and examination, followed by imaging selected according to symptoms and local expertise. The pathway should remain flexible because age, pregnancy plans, access to specialist imaging, prior treatment, and severity all influence the appropriate sequence.

1. Document the pain pattern, menstrual symptoms, bowel and bladder symptoms, sexual pain, fertility concerns, family history, previous treatments, and functional impact.
2. Perform an appropriate abdominal and pelvic examination, with consent and adaptations for comfort, trauma history, age, or inability to tolerate an internal examination.
3. Arrange a transvaginal ultrasound when acceptable and clinically appropriate, preferably with an examiner experienced in identifying endometriosis and its indirect signs.
4. Consider specialist ultrasound or pelvic MRI when deep endometriosis, bowel or bladder involvement, adenomyosis, an indeterminate mass, or complex surgical planning is suspected.
5. Use targeted laboratory tests to assess pregnancy, anemia, infection, urinary disease, gastrointestinal disease, or other alternatives—not as a substitute for imaging.
6. Discuss a monitored empirical treatment trial when appropriate, including expected benefits, risks, fertility implications, and a planned review.
7. Refer for specialist assessment when symptoms persist, imaging shows an endometrioma or deep disease, infertility is present, treatment is unsuccessful, or the diagnosis remains uncertain.

A useful clinical record can include a pain score from zero to ten, the number of days affected each month, bleeding severity, bowel and urinary symptoms, medication effects, and missed activities. These measures help show whether a treatment plan is working and provide objective context when deciding whether further imaging or surgery is justified.

Conclusion: Non-Surgical Evaluation of Suspected Endometriosis

Non-surgical evaluation of suspected endometriosis combines symptom history, pelvic examination, transvaginal ultrasound, specialist imaging, pelvic MRI, targeted laboratory testing, and carefully monitored treatment. Ultrasound is generally the first-line imaging test, while MRI and expert ultrasound can map deep disease and support planning. CA-125 and other proposed biomarkers are not reliable stand-alone diagnostic tools, and a normal scan cannot exclude superficial endometriosis.

The broader importance of this approach is that patients can receive evidence-based assessment and symptom treatment without automatically undergoing surgery, while still having a route to specialist review when non-surgical methods are inconclusive. Anyone with persistent, disabling, or progressive cyclical pelvic symptoms should keep a symptom record and discuss an individualized evaluation with a qualified clinician rather than accepting severe menstrual pain as normal.

Sources: World Health Organization, Endometriosis, 2023, https://www.who.int/news-room/fact-sheets/detail/endometriosis; European Society of Human Reproduction and Embryology, ESHRE Guideline: Endometriosis, 2022, https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline; National Institute for Health and Care Excellence, Endometriosis: Diagnosis and Management, NICE Guideline NG73, updated 2024, https://www.nice.org.uk/guidance/ng73; American College of Obstetricians and Gynecologists, Dysmenorrhea and Endometriosis in the Adolescent, Committee Opinion No. 760, reaffirmed 2025, https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent; Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML, Cochrane Database of Systematic Reviews, Imaging modalities for the non-invasive diagnosis of endometriosis, 2016, https://doi.org/10.1002/14651858.CD009591.pub2; National Institute for Health and Care Excellence, Suspected Cancer: Recognition and Referral, NICE Guideline NG12, updated 2025, https://www.nice.org.uk/guidance/ng12